Profile for European Patent Office Patent: 1499331
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | C300615 | ⤷ Start Trial |
| Estonia | C20130010 00080 | ⤷ Start Trial |
| France | 13C0055 | ⤷ Start Trial |
| Germany | 122014000007 | ⤷ Start Trial |
| Belgium | 2013C/049 | ⤷ Start Trial |
| United Kingdom | SPC/GB13/034 | ⤷ Start Trial |
| Romania | C 2013 026 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1499331
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
